Feed / EBS

Emergent BioSolutions Inc.

EBS

Healthcare · 4.84 -39.6% today

Isolated · not yet confirmedMarket checked 20 Aug, 09:30 GMT-4

Jodie situation report

Emergent BioSolutions Inc.'s current read is isolated; its market group is not confirming.

No new filing conclusion is available. 0 of 18 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 4 directly disclosed connections are confirming.

Company-39.6% todayVolume comparison unavailable
Market group0 of 18 activeHealthcare Biotech & REITs · unavailable
Disclosed network0 of 4 confirmingNo filing-linked name is confirming now
What would change this read
  • EBS's market-adjusted activity becomes unusual and at least one connected name confirms.

Invalidation: The isolated read changes if EBS's group or a disclosed connection begins moving with it.

Watch this read

Who this business touches

The relationships behind EBS

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

BORAYFiling-linked namesupplierAug 7, 2025

The loss on assets held for sale in the second quarter of 2024 is related to the sale of our Drug Product facility in Baltimore-Camden to Bora Pharmaceuticals Injectables Inc., a subsidiary of Bora Pharmaceuticals Co., Ltd.

NATNordic American Tankers LimitedpartnerFeb 27, 2026

In addition, the Company recognized $20.0 million of incremental income from milestone payments received in 2025 related to the sale of our travel health business to Bavarian Nordic, as well as favorable impacts from interest income increase and foreign curre…

Depended on by

SPRYARS Pharmaceuticals, Inc.customerMar 9, 2026

Our commercial team is led by Eric Karas, Chief Commercial Officer, who has more than 25 years of sales, marketing, market access and strategic planning experience across multiple specialty products, including leading commercial initiatives for NARCAN nasal s…

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 1 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

EBS is currently a Follower in the organic co-movement group Healthcare Biotech & REITs. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

This group is retained as the last observed read for EBS; it is not active in the latest market snapshot.